Olivier Bogillot
Förmögenhet: 27 290 $ per 2026-08-31
Förmögenhet: 27 290 $ per 2026-08-31
Olivier Bogillot is currently Chairman at Sanofi Pasteur Merieux SAS since 2020.
Formerly, Dr. Bogillot was Chairman & Chief Executive Officer at Sanofi-Aventis France SA and President & Director at Provention Bio, Inc. Dr. Bogillot earned a doctorate from the University of Lyon.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
CLARIANE SE 0 % | 2025-12-31 | 5 897 ( 0 % ) | 27 290 $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| CLARIANE SE | Direktör/Styrelseledamot | 2025-05-14 |
Sanofi Pasteur Merieux SAS
Sanofi Pasteur Merieux SAS Financial ConglomeratesFinance Engages in activities of holding companies | Ordförande | 2020-03-01 |
| Företag | Position | Slut |
|---|---|---|
Sanofi-Aventis France SA
Sanofi-Aventis France SA Medical DistributorsDistribution Services Wholesales pharmaceutical products | Verkställande Direktör | - |
| PROVENTION BIO, INC. | President | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
Clariane SE
Clariane SE Medical/Nursing ServicesHealth Services Operates retirement homes | Health Services |
University of Lyon
University of Lyon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi Pasteur Merieux SAS
Sanofi Pasteur Merieux SAS Financial ConglomeratesFinance Engages in activities of holding companies | Finance |
Sanofi-Aventis France SA
Sanofi-Aventis France SA Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
Provention Bio, Inc.
Provention Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company that engages in intercepting and preventing immune-mediated diseases including type 1 diabetic activities | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån